Visit Bioiberica at booth #6643 from 23-27 October to discover the latest scientific studies supporting Mobilee^® and Dermial^® and unlock new opportunities for mobility and skin health innovation. 

Bioiberica, a global life science company with over 45 years of experience in the research of molecules of high biological and therapeutic value for the pharmaceutical and nutraceutical industries, is returning to SupplySide West to spotlight the latest science behind its industry-first hyaluronic acid matrix ingredients – Mobilee^® for mobility and Dermial^® for skin & beauty. Visitors are invited to discover new research on the effect of Mobilee^® on muscle health and the enhanced antioxidant properties of Dermial^® compared to traditional HA.

The company will also showcase its wider portfolio of scientifically-backed ingredients for mobility, including Collavant n2 (native (undenatured) type II collagen), Tendaxion (tendon health ingredient), and CSbioactive^® (chondroitin sulfate), as well as DAOgest – a premium diamine oxidase (DAO) enzyme ingredient for digestive health. 

Research inspiring innovation 

Earlier this year, Bioiberica presented the results of the first phase of an ongoing scientific study on Mobilee^®, demonstrating the effects of its three naturally occurring components – HA, polysaccharides, and collagen – on muscle health, suggesting the matrix ingredient may play a role against sarcopenia.¹ At SupplySide West, the company is set to highlight the findings of a second phase of this study, due to be announced ahead of the show. Both studies add to a growing bank of evidence supporting Mobilee^®’s potential in muscle health. The Bioiberica team will be on hand to discuss the new findings, presenting formulators with an exciting opportunity to develop new nutritional solutions for the mobility market. 

Supplement manufacturers exploring new opportunities for skin health innovation can also uncover the latest insights from a recent peer-reviewed paper published in the International Journal of Molecular Sciences, suggesting that Dermial^® may present regenerative, antioxidant properties in skin cells. This is the first time the ingredient’s role against oxidative stress has been exhibited – adding to the growing body of scientific evidence demonstrating its benefits. 

Discovering new opportunities 

“The US market is a key priority for Bioiberica, so we’re excited to return to SupplySide West to meet with our new and long-standing partners once again,” comments Joan Bassa, Human Health Business Unit Director at Bioiberica. “We’re looking forward to sharing the latest scientific evidence supporting the effectiveness of Mobilee^® and Dermial^®, in line with our ongoing goal to empower the health evolution by inspiring new opportunities for product development in the mobility and skin health space.” 

To learn more about Bioiberica’s science-backed portfolio, stop by booth #6643 at SupplySide West or visit www.bioiberica.com. 

About Bioiberica 

Bioiberica is a global life science company with more than 45 years’ experience in the research, production, and commercialisation of molecules of high biological and therapeutic value for the pharmaceutical, nutraceutical, and food industries. 

This specialisation positions Bioiberica as a leader in the manufacture of the active pharmaceutical ingredient (API) heparin, as well as a world reference in the production of other biologically-derived APIs and scientifically-backed branded ingredients suitable for mobility, digestive health, and skin & beauty. 

Bioiberica’s long-standing reputation is the result of its passion for life and science. Through its vertically-integrated supply chain, the company has complete control of its end-to-end production processes – ensuring the highest quality, safety, and full traceability of its products. With production sites in Europe and the US, Bioiberica currently exports to more than 80 countries worldwide. 

Committed to our partners’ success, Bioiberica is the perfect partner with which to explore new opportunities and developments in human health.